Contact
Please use this form to send email to PR contact of this press release:
Inventiva announces positive results from Phase IIa clinical study with odiparcil in mucopolysaccharidosis type VI
TO:
Please use this form to send email to PR contact of this press release:
Inventiva announces positive results from Phase IIa clinical study with odiparcil in mucopolysaccharidosis type VI
TO: